NCT03469336 Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT03465696 A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis Status COMPLETED Phase NA
NCT03455166 Identification of New Prognostic Markers in Psoriatic Arthritis Status COMPLETED Phase NA
NCT03453190 Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis Status UNKNOWN Phase PHASE4
NCT03451851 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03448081 Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene Status COMPLETED Phase PHASE2
NCT03445013 A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis Status COMPLETED Phase PHASE1
NCT03440736 Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT03440541 Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment Status COMPLETED Phase NA
NCT03431974 Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis Status COMPLETED Phase PHASE2
NCT03423004 Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin Status COMPLETED Phase NA
NCT03421197 A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Status COMPLETED Phase PHASE2
NCT03419910 An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT03418493 A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis Status COMPLETED Phase PHASE1
NCT03409211 Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis Status COMPLETED Phase NA
NCT03406117 A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests Status COMPLETED Phase PHASE4
NCT03403036 Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies Status COMPLETED Phase PHASE4
NCT03399526 1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat Status COMPLETED Phase PHASE1
NCT03392337 An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients Status RECRUITING Phase NA